← All organizations

Biscayne Neurotherapeutics, Inc.

For profit

Also known as: Biscayne Neurotherapeutics Australia Pty, Ltd. | Biscayne Neurotherapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 2, 2018

Acquired by Supernus Pharmaceuticals on Sep 14, 2018

Timeline

2010s

Jun 1, 2011
Biscayne Neurotherapeutics, Inc.— Founded
Sep 14, 2018
Supernus Pharmaceuticals— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

huperzine a

Indications

Studied for

Recent trials (4)

NCT03474770CollaboratorPhase 1/Phase 2Apr 2, 2018
NCT03474770Study chairPhase 1/Phase 2Apr 2, 2018
NCT03474770Lead sponsorPhase 1/Phase 2Apr 2, 2018
NCT03156439Lead sponsorPhase 1May 22, 2017

Details

Founded: Miami, FL, US Jun 1, 2011
Last known activity: Apr 2, 2018